Sam Eiber

Stock Analyst at BTIG

(n/a)

# 4,741

Out of 4,853 analysts

4

Total ratings

n/a

Success rate

-10.58%

Average return

Main Sectors:

Top Industries:

Medical Devices Drug Manufacturers - Specialty & Generic

Stocks Rated by Sam Eiber

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	INMD InMode	Downgrades: Neutral	n/a	$14.37	-	2	Apr 29, 2025
	EOLS Evolus	Initiates: Buy	$21	$9.78	+114.72%	1	Apr 17, 2025
	APYX Apyx Medical	Initiates: Neutral	n/a	$1.65	-	1	Oct 17, 2024

InMode

Apr 29, 2025

Downgrades: Neutral

Price Target: n/a

Current: $14.37

Upside: -

Evolus

Apr 17, 2025

Initiates: Buy

Price Target: $21

Current: $9.78

Upside: +114.72%

Apyx Medical

Oct 17, 2024

Initiates: Neutral

Price Target: n/a

Current: $1.65

Upside: -